Overview A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema Status: Completed Trial end date: 2003-06-01 Target enrollment: Participant gender: Summary To determine the efficacy and safety of intravitreal triamcinolone acetonide for refractory diabetic macular edema. Phase: Phase 2 Details Lead Sponsor: Shahid Beheshti University of Medical SciencesTreatments: TriamcinoloneTriamcinolone AcetonideTriamcinolone diacetateTriamcinolone hexacetonide